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Abstract
The pathogenicity of the periodontal biofilm is highly dependent on a few key species, of 
which Porphyromonas gingivalis is considered to be one of the most important pathogens. 
P. gingivalis expresses a broad range of virulence factors, of these cysteine proteases (gin­
gipains) are of special importance both for the bacterial survival/proliferation and for the 
pathological outcome. Several cell types, for example, epithelial cells, endothelial cells, 
dendritic cells, osteoblasts, and fibroblasts, reside in the periodontium and are part of the 
innate host response, as well as platelets, neutrophils, lymphocytes, and monocytes/mac­
rophages. These cells recognize and respond to P. gingivalis and its components through 
pattern recognition receptors (PRRs), for example, Toll-like receptors and protease-acti­
vated receptors. Ligation of PRRs induces downstream-signaling pathways modifying the 
activity of transcription factors that regulates the expression of genes linked to inflamma­
tion. This is followed by the release of inflammatory mediators, for example, cytokines and 
reactive oxygen species. Periodontal disease is today considered to play a significant role 
in various systemic conditions such as cardiovascular disease (CVD). The mechanisms by 
which P. gingivalis and its virulence factors interact with host immune cells and contribute 
to the pathogenesis of periodontitis and CVD are far from completely understood.
Keywords: host-microbe interaction, immune cells, pathogen recognition receptors, 
intracellular signaling, inflammatory responses, Porphyromonas gingivalis, gingipains, 
LPS, cardiovascular disease, treatment
1. Introduction
Evidence suggests that it is the early host-inflammatory and immune responses to the oral 
microbiota that changes the subgingival environment and favors the emergence of periodontal 
© 2017 The Author(s). Licensee InTech. This chapt r is distributed under the terms of the Creative Comm s
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opportunistic pathogens during the development of periodontitis. Substances released from 
the dental biofilm, such as lipopolysaccharides, proteolytic enzymes, and other virulence fac­
tors, activate the innate immune system and initiate an inflammatory response, which disrupts 
the host-microbe homeostasis. The activation of immune cells leads to a release of an array 
of inflammatory mediators, for example, cytokines, chemokines, proteases, reactive oxygen 
species (ROS), and eicosanoids, which struggle against the bacterial burden. However, the 
complexity of the microbial biofilm of the subgingival dental plaque and the failure of the 
acute inflammation to resolve lead to an accumulation of mediators of the innate and adap­
tive immune systems that collectively promote chronic inflammation and tissue destruction. 
How host cells discriminate commensal from pathogenic microbial species and why this abil­
ity seems to differ between individuals is currently unknown. The variation in individual 
susceptibility to develop periodontal disease appears to be determined by the magnitude of 
the inflammatory response to a dysbiotic microbial community and whether only the innate 
or also the adaptive immune pathways are activated.
2. Porphyromonas gingivalis in periodontitis
There are a number of bacterial species that are associated to periodontitis, based on their 
detection in periodontal pockets, their pathogenicity, and the immunological responses they 
evoke [1]. The red complex is a consortium of three periodontal bacterial species, Treponema 
denticola, Tannarella forsythia, and Porphyromonas gingivalis, which are linked to each other and 
to diseased sites [2]. The development and progression of periodontitis is believed to be due 
to a synergistic and dysbiotic polymicrobial community, and the oral biofilm (dental plaque) 
[3]. A biofilm is a highly structured, three-dimensional matrix with a simple circulatory sys­
tem. The biofilm provides physical protection and a gradient of oxygen, allowing anaerobic 
species to grow in the deeper pocket, and aerobic species near the surface. Furthermore, meta­
bolic by-products from one species can be used as nutrients by other species in the biofilm, 
the so-called cross-feeding [4]. The keystone species hypothesis suggests that some species, 
like P. gingivalis, exerts a disproportionally large effect in the biofilm. P. gingivalis can turn 
from a natural low-abundance microorganism residing in the oral cavity to an opportunistic 
pathogen that interferes with the host immune system and from a normal, symbiotic micro­
biota, and enables the transition and emergence into a dysbiotic bacterial society that drives 
the progress of periodontitis [2, 5]. P. gingivalis is a late colonizer usually found in a rather low 
number in the dental plaque, and interestingly, P. gingivalis is not able to induce periodon­
titis in germ-free mice, suggesting that P. gingivalis is dependent on the complex microbial 
community. Through synergistic interactions, the biofilm promotes colonization, nutrition 
 acquisition and subvert, and evades host immune responses [4, 6].
P. gingivalis is a non-motile, proteolytic, and Gram-negative rod that expresses several virulence 
factors that are related to colonization of oral tissues, periodontal tissue destruction, and evasion 
of the host responses [7]. P. gingivalis exhibits genotypic and phenotypic diversity, which results 
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in differences in virulence and in the capacity of individual strains to colonize and induce destruc­
tion of periodontal tissues. Certain strains may therefore exhibit a higher pathogenic potential 
than others and may be linked to a more severe form of periodontitis [8–12]. The asaccharolytic 
bacterium P. gingivalis grows under anaerobic conditions and acquires metabolic energy by fer­
menting amino acids. P. gingivalis also uses micronutrients, such as metal ions for anabolic and 
catabolic purposes, as well as vitamin K. P. gingivalis expresses a broad range of virulence factors, 
all of which add to enhanced growth and survival in a hostile environment [7]. However, the 
virulence of P. gingivalis is affected by its surroundings, including other bacterial species in the 
biofilm and host-derived factors. By altering the gene expression of virulence factors, P. gingivalis 
can adjust to a more or less virulent phenotype depending on the environment [13].
Fimbriae are hair-like protrusions emanating from the outer cell surface that facilitate the 
adherence and colonization of the bacterium. Indeed, fimbriae are critical for mediating 
the initial bacterial interaction with the host tissue. P. gingivalis expresses major and minor 
fimbriae, encoded by the fimA and mfa1 genes, respectively. Today, six fimA allele types are 
known (fimA I, Ib, II, III, IV, and V). These variants are more or less associated to periodon­
titis [14]. P. gingivalis isolated from periodontally healthy persons more often expresses 
type I, II, or V. Types Ib, II, and IV, on the other hand, are more associated to diseased 
periodontal pockets [9, 15]. Major fimbriae can attach and bind to host cells, extracellular 
matrix (ECM), as well as salivary proteins. Major fimbriae can also facilitate binding to 
other bacteria, both P. gingivalis itself and other species. Minor fimbriae have a role in bio­
film formation [14, 16].
As a Gram-negative species, P. gingivalis possesses lipopolysaccharides (LPS). Intriguingly, 
the lipid A part of P. gingivalis LPS has a structure that is heterogeneous. The number of asso­
ciated fatty acids coupled to the disaccharide core varies, resulting in penta- or tetra-acylated 
lipid A moieties that allows interaction with both Toll-like receptors (TLR) 2 and TLR4 [17]. 
It is the availability of hemin in the microenvironment that defines which lipid A form that 
P. gingivalis expresses, enabling the bacteria to determine how it interacts with the host to 
elicit various inflammatory responses [8, 18].
Gingipains are cysteine proteases which probably are the most vital virulence fac­
tor expressed by P. gingivalis. Gingipains are membrane-bound, as well as secreted from 
the bacterium, thus, P. gingivalis can exert all the various gingipain activities at dis­
tant sites. P. gingivalis possesses arginine-specific gingipains, Rgp (RgpA and RgpB), 
encoded by rgpA and rgpB, respectively, and the lysine-specific gingipain, Kgp, encoded 
by kgp. P. gingivalis expresses numerous proteolytic enzymes, but the gingipains are 
by far the most important ones, accounting for at least 85% of the total proteolytic activ­
ity. Furthermore, they are implicated and play key roles in adherence and colonization 
of the host, in nutrition acquisition by cleaving host proteins, in neutralization of host 
defense mechanisms, and in manipulation of the host inflammatory response. In sum­
mary, gingipains are vital for bacterial survival and proliferation in vivo [7]. In the process 
of adherence and colonization, P. gingivalis utilizes fimbrial adhesions, but nevertheless, 
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gingipains are also necessary in these steps. RgpA and Kgp contain hemagglutinin-adhesin 
domains, which are directly involved in conjugation with other bacterial species, thereby pro­
moting the construction of the bacterial biofilm. These domains also enable binding to ECM, 
as well as interaction with host cells [19–21]. Rgp is also important for processing various 
P. gingivalis-derived proteins. For instance, Rgp is necessary for the modification of major 
fimbriae to the mature form [22]. Gingipains are also key mediators in dysregulation of the 
host immune response [23, 24].
Some P. gingivalis strains possess a capsule. Encapsulated strains are more virulent since they 
have been shown to be more invasive and more resistant to phagocytosis [25–27]. P. gingivalis 
also releases outer membrane vesicles, small cargos that are shed from the outer bacterial 
membrane that are loaded with LPS, gingipains and other proteases, fimbriae, and capsule 
(encapsulated strains). The shedding of outer membrane vesicles occurs at a higher rate during 
colonization and biofilm formation, enabling immune modulation at sites distant from the 
actual site of infection [28].
3. Mechanisms of P. gingivalis interaction with host cells
P. gingivalis, as a keystone pathogen, has the ability to interfere with the host in such ways 
that the growth and survival of the entire biofilm is promoted and enhanced. It is vital for 
P. gingivalis in a hostile environment to be able to counteract, modify, and manipulate the 
host immune response in order to survive and evade the various host defense mechanisms. 
Although it is important to evade the host defense mechanisms, it is also of essential impor­
tance to induce inflammation to secure a constant delivery of nutrients to the biofilm through 
the formation of the nutrient-rich-inflammatory exudate that constitutes the gingival crevicu­
lar fluid. P. gingivalis has indeed evolved elaborated strategies to diminish as well as promote 
inflammation [5]. The complement system, which targets microbes, is itself a target for pro­
teolysis by gingipains. In fact, P. gingivalis can both inhibit and stimulate the complement 
system [29]. Also, depending on the type of lipid A expressed, P. gingivalis can act as both a 
TLR4 agonist and an antagonist and regulate the TLR4-dependent immune responses [10, 
18]. Realizing all the clever ways of escaping, it may not come as a surprise that P. gingivalis, 
as an additional function on the repertoire, also is resistant to oxidative killing by phagocytes 
and can survive phagocytosis by macrophages [26, 30]. Furthermore, P. gingivalis is able to 
activate the coagulation cascade and the kallikrein/kinin cascade, thereby enhancing inflam­
mation [31–33]. P. gingivalis can invade host cells and replicate within the cell [34]. P. gingivalis 
is also able to protect itself from neutrophil-released reactive oxygen species, leaving the oxi­
dative burst effortless and instead contributing to the destruction of the periodontium [13, 30].
The interactions between the host immune system and the oral microbial flora involve complex 
cellular and molecular mechanisms. Several cell types, for example, epithelial cells, dendritic cells, 
osteoblasts, and fibroblasts that reside in the periodontium, are part of the innate host response, 
as well as platelets, neutrophils, and monocytes/macrophages. Cells of the innate immune system 
recognize and respond to pathogens (e.g., LPS, fimbriae, DNA, and proteases) through patho­
gen recognition receptors (PRRs). Important PRRs are TLRs and  protease-activated  receptors 
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(PARs). Ligation of PRRs induces downstream signaling pathways that modify the activity of 
transcription factors that regulates the expression of genes linked to inflammation. Early cel­
lular events leading to a phosphorylation cascade of mitogen-activated protein kinase (MAPK) 
signaling include the activation of Protein kinase C (PKC) by diacylglycerol and calcium. Signals 
transduced via MAPK pathways lead to the assembly and activation of the transcription fac­
tor AP-1. TLR activation results in the recruitment of an adaptor protein, which in many cases 
involves MyD88, followed by a signaling cascade that phosphorylates, polyubiquitylates, and 
degrades IκB. This allows the transcription factor NFκB to translocate to the nucleus and induces 
gene expression (Figure 1). AP-1, NFκB, and other transcription factors cooperatively regulate 
genes, such as inflammatory mediators and growth factors that are important in many biological 
processes [35, 36]. This is followed by the release of inflammatory mediators such as CXCL8 and 
interleukin (IL)-6. The chemokine CXCL8 attracts and recruits neutrophils to the site of infec­
tion and promotes monocyte adhesion to the vessel wall. The infiltrating neutrophils, as well as 
resident cells and macrophages, release cytokines, such as tumor necrosis factor-α (TNF-α), IL-1, 
Figure 1. Overview of receptors and intracellular signaling pathways in response to virulence factors of P. gingivalis. See 
text for details.
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and IL-6. These inflammatory mediators will eventually contribute to tissue destruction with 
alveolar bone loss and a sustained chronic inflammation. In addition, the innate immune system 
will in turn also activate the adaptive immune system with the involvement of lymphocytes [1, 
2, 5].
How host-derived factors such as cytokines, hormones, and reactive oxygen species affect 
periodontal biofilm formation and bacterial virulence is poorly studied and thus not well 
understood. A recent study suggests that the host-inflammatory responses affect the physiol­
ogy of bacteria, for example, by utilizing inflammatory mediators as transcription factors [37]. 
It thus seems quite reasonable that bacteria have evolved mechanisms to sense their environ­
ment and to respond to their surrounding by using inflammatory mediators as regulators to 
be able to adjust and adapt to a changing environment. Consequently, it is possible that early 
host-inflammatory and immune responses affect and modulate the composition and function 
of the oral biofilm and the progression of periodontitis.
TLRs are a family of receptors which are of high importance in the innate immune response 
in sensing pathogens and other danger-associated signals. LPS and fimbriae originate from 
P. gingivalis signals mainly through TLR2, which mediates the release of inflammatory media­
tors like CXCL8 [38–40]. P. gingivalis-mediated activation of TLR2 has been demonstrated to 
stimulate differentiation and formation of osteoclasts [40]. A study showed that TLR2−/− mice 
more rapidly cleared P. gingivalis infection, had a more efficient phagocytosis of P. gingivalis, 
and also resisted alveolar bone loss despite being repeatedly infected with P. gingivalis [41]. 
TLR2 expression has also been found to be upregulated by P. gingivalis [42]. During inflam­
mation, the hemin concentration in the gingival crevicular fluid is high and the tetra-acylated 
lipid A form is expressed. The tetra-acylated lipid A is acting as a TLR4 antagonist, suppressing 
TLR4-mediated inflammatory events. The TLR4 antagonist also competitively blocks the bind­
ing of TLR4; hence, TLR4 is unable to respond to other bacterial species as well. In addition, 
since the outer membrane vesicles contain LPS, and can penetrate through the gingival tissue, 
P. gingivalis can dampen the TLR4 effects for the entire oral microbial community. When the 
hemin concentration is low, inflammation is promoted by expressing penta-acylated lipid A, 
which works as a TLR4 agonist [10, 18, 43].
PARs have been found to be activated by proteolytic cleaving by gingipains, leading to 
increased inflammatory response with the release of inflammatory chemokines [39, 44]. PAR2 
activation has been demonstrated to induce alveolar bone loss in rats. Since PAR2 is expressed 
by the cells in the periodontium, P. gingivalis and its gingipains are able through PAR2 activa­
tion to significantly contribute to the release of several pro-inflammatory mediators that cause 
degradation of the periodontal tissue [45]. Furthermore, P. gingivalis per se has been demon­
strated to upregulate the PAR2 expression in gingival fibroblasts [39].
A gradient of CXCL8 is normally established in the healthy periodontal tissue with the 
highest concentration at the border of the symbiotic dental plaque. This gradient estab­
lishes a “wall” of neutrophils, a continuous flow of migrating neutrophils that transit from 
the vasculature into the periodontium and the gingival crevice. P. gingivalis can interact 
with CXCL8 and this gradient in several ways [2]. In contact with gingival epithelial cells, 
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P. gingivalis expresses phosphoserine phosphatase SerB, which contributes to CXCL8 
inhibition [46]. Gingipains are well known to cleave CXCL8, as well as other cytokines 
and chemokines, such as IL-6, IL-6 receptor, CXCL10, TNF-α, CD14, IL-4, and IL-12 [23, 
24, 44, 47–52]. By targeting inflammatory mediators such as CXCL8, the resulting chemo­
kine paralysis leads to inhibited neutrophil recruitment, thereby promoting the growth 
of the biofilm. Consequently, P. gingivalis undermines innate immunity [2]. Furthermore, 
CXCL8 is secreted in two different isoforms, as a 72 amino acid (CXCL8-72aa) variant 
from immune cells and as a 77 amino acid variant (CXCL8-77aa) from non-immune cells 
such as fibroblasts. CXCL8-72aa is a stronger chemoattractant than CXCL8-77aa, but after 
cleavage of CXCL8-77aa by gingipains, this is shifted so that the CXCL8-77a has a higher 
chemotactic potential. This could be a mechanism whereby P. gingivalis, by creating a gra­
dient of gingipains across the periodontal tissue can suppress neutrophilic response in the 
periodontal pocket where the concentration of gingipains is the highest. At a more distant 
site, with lower concentrations of gingipains, the chemotactic function of CXCL8-77aa is 
increased, enhancing the inflammatory response and thereby promoting leaky vessels 
and a constant delivery of nutrients to the biofilm [47, 53].
4. Host cell responses in the oral cavity
4.1. Gingival epithelial cells
The first line of host defense in the gingiva consists of the epithelial cells forming a physi­
cal barrier against mechanical stress, exogenous substances, and pathogenic bacteria. This is 
achieved through different cell-cell junctions, including tight junction and gap junction. P. gin-
givalis uses different strategies to survive and persist in the oral cavity, and invasion of epithe­
lium is one tactical approach in its lifestyle. The advantages of intracellular translocation of 
P. gingivalis into the cells include evasion from immune responses and antibiotics, and accessi­
bility to disseminate to other sites, which collectively leads to persistence and proliferation [4]. 
The mechanism by which P. gingivalis enters epithelial cells is initiated by fimbriae that bind 
to α5β1-integrin, followed by the formation of cellular pseudopodia and entry through early 
endosomes. Intracellular bacteria are then either sorted to late endosomes followed by lyso­
somes for degradation, or fused with autophagosomes and subsequently degraded in autoly­
sosomes. However, a large number of bacteria are able to escape through recycling pathways 
for exocytosis and are able to infect new cells, which facilitate deeper penetration into the host 
tissue [54]. While in other cell types, such as endothelial and smooth muscle cells, P. gingivalis 
has been reported to reside and persist within autophagosomes, followed by the prevention of 
lysosomal fusion and formation of autolysosomes [55, 56]. Interestingly, α5β1-integrin on epi­
thelial cells has recently been shown to positively correlate with cells in S phase of the cell cycle, 
and P. gingivalis persistence may be associated with the ability to preferentially target dividing 
cells [57]. The virulence of intracellular P. gingivalis is associated with its ability to degrade pax­
illin and focal adhesion kinase, and may explain the significant periodontal tissue degradation 
and lack of wound healing and tissue regeneration processes in periodontitis [58, 59].
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Epithelial cells also participate in innate immune responses by secreting a variety of cyto­
kines and chemokines, such as TNF, IL-6, and CXCL8 [60]. P. gingivalis suppresses cytokine 
and chemokine accumulation below basal levels in vitro. These effects are most probably 
due to the potent enzymatic action of proteinases. Indeed, leukocytes are manipulated by 
P. gingivalis to express a limited repertoire of inflammatory mediators, while suppressing 
CXCL8 release, which is termed “local chemokine paralysis” [61]. Interestingly, P. gingivalis  
significantly increased TGF-β1 expression from gingival epithelial cells. TGF-β1 functions 
as a growth factor with anti-inflammatory characteristics. Besides TGF-β1, P. gingivalis was 
observed to induce the expression of a wide array of different growth factors, including 
Insulin-like growth factor (IGF), Platelet-derived growth factor (PDGF), endothelial growth 
factor (EGF), and Hepatocyte growth factor (HGF). We have previously shown that P. gingivalis 
induces high levels of HGF in clinical samples from patients with periodontitis. However, the 
activity of HGF was significantly reduced in patients compared to healthy controls [62].
4.2. Gingival fibroblasts
Gingival and periodontal ligament fibroblasts are the main cell types found in the connective tissue 
of the periodontium, and they are exposed to pathogens once the epithelial barrier is breached [2, 
63]. Fibroblasts provide a structural tissue framework (stroma) and define the microanatomy of the 
tissue with the key function to regulate and maintain integrity of the connective tissue. Homeostasis 
of connective tissues is maintained through the production of ECM and by modifying existing 
ECM by secreting matrix metalloproteinases (MMPs) that cleave and degrade ECM components 
[64]. The ability of fibroblasts to secrete as well as respond to growth factors and cytokines/chemo­
kines allows reciprocal communication with adjacent cells that facilitates homeostasis of the tissue. 
Considering the functions of fibroblasts makes it easy to realize that fibroblasts play a vital role in 
tissue development, differentiation, and repair. Fibroblasts are also of importance in tissue destruc­
tion by the release of MMPs and pro-inflammatory cytokines and chemokines [63–65]. PAR1 and 
TLR2 have been shown to be important in the interaction between gingival fibroblasts and P. gin-
givalis. Gingival fibroblasts can sense P. gingivalis through PAR1 and TLR2, and the activation of 
these receptors leads to the secretion of CXCL8 and IL-6, suggesting that fibroblasts could make a 
substantial contribution to the inflammatory process seen in periodontitis [38, 39, 66]. Furthermore, 
P. gingivalis is able to modify this response by cleaving fibroblast-derived cytokines through the 
proteolytic activity of the gingipains and thereby hampering the antimicrobial capacity of the 
fibroblasts [23, 24, 66].
4.3. Leukocytes
Periodontitis is characterized by interaction between a number of oral pathogens, such as 
P. gingivalis, and blood leukocytes. Neutrophils and monocytes are well equipped with PRRs, 
such as TLRs, nuclear-oligomerizing domains ½, and PARs. This arsenal of receptors enables 
the detection of invading pathogens and production of reactive oxygen species, cytokines, 
and chemokines. We have shown that P. gingivalis is capable of inducing ROS in isolated neu­
trophils and in whole blood, and stimulating the release of inflammatory mediators, such as 
IL-1β and CXCL8 [67]. Both these cytokines are capable of priming neutrophils, endothelial 
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cells, and other vascular cells in an autocrine and paracrine manner. Studies have demon­
strated that gingipains hydrolyze pro-inflammatory cytokines, but not growth factor/anti-
inflammatory cytokines, which result in aberrant immune cell recruitment to the site of 
infection, ensuring a continued low-grade infection.
The critical balance of different T-cell subsets has previously been described to play an impor­
tant role in the inflammatory process underlying periodontitis. The presence of specific antibod­
ies for oral bacteria in patients with periodontitis indicates an involvement of adaptive immune 
responses [68], of which different T-cell subsets play a detrimental role in the pathogenesis of 
this inflammatory disease. The T-cell-associated cytokine profile in gingival tissue suggests an 
engagement of T-helper (Th) 1, Th2, and Th17 cells [69–71]. These T-cell subsets are associated 
with host-derived tissue destruction and bone loss, through, for example, Receptor activator of 
nuclear factor kappa-B ligand (RANKL) expression. Exaggerated pro-inflammatory responses 
from T-cells can be controlled by regulatory T-cells (Tregs) that display protective effects through 
the secretion of anti-inflammatory IL-10 and TGF-β1. Tregs have a central role in maintaining 
homeostasis by regulating other leukocyte functions and thereby avoiding extensive immune 
cell activation and its pathological consequences, for example, in periodontitis. Interestingly, 
we have previously shown that T-cell interaction with P. gingivalis leads to a gingipain-medi­
ated inactivation of IL-2 [72], which may thus downregulate Tregs and support the process of 
periodontitis. Thus, the inhibition of gingipains and maintenance of a Treg-mediated beneficial 
homeostasis may be a successful strategy for the prevention and treatment of periodontitis.
5. Periodontitis, systemic inflammation, and cardiovascular disease
Periodontal disease is today considered to play a significant role in various systemic con­
ditions and, in the past decade, the enhanced prevalence of cardiovascular disease (CVD) 
among patients with periodontitis has received increased attention [73, 74]. Several peri­
odontal bacteria and their agents have been identified in atherosclerotic plaques, for exam­
ple, P. gingivalis, Fusobacterium nucleatum, T. forsythia, Prevotella intermedia, Aggregatibacter 
 actinomycetecomitans, and T. denticola [75–78]. The occurrence of periodontal bacteria in cor­
onary artery plaques was found to be 5-fold greater in patients with severe  periodontitis 
compared to those with medium periodontitis [79], and DNA from periodontal bacteria, 
including P. gingivalis, was identified in more than 70% of carotid plaque samples [80]. 
Furthermore, P. gingivalis has been shown to influence the development of abdominal aorta 
aneurysm, involving the activation of TLRs and MMPs [81]. Several animal experiments 
have demonstrated that oral and systemic infection with periodontal bacteria induces athero­
sclerosis [74]. Hokamura and Umemura [82] showed that the administration of P. gingivalis  
in a mouse model induces arterial intimal hyperplasia associated with upregulation of the 
calcium-binding protein S100A9.
When the periodontal disease develops, the gingival epithelium becomes ulcerated by proteo­
lytic activity, for example, by P. gingivalis, leading to exposure of the underlying  connective 
tissues and blood capillaries to the bacterial plaque biofilm. At medium periodontitis, the 
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ulcerative area in the oral cavity ranges between 8 and 20 cm2, which means that large amounts 
of periodontal bacteria and their toxins and metabolic products have a chance, during chew­
ing and oral hygiene activities, to disseminate into the bloodstream and cause transient bac­
teremias and systemic inflammation [74]. By entering the circulation, the bacteria and/or their 
components (e.g., proteases, fimbrillin, and LPS) activate platelets and neutrophils, induce 
ROS production, and trigger inflammatory processes in coronary vessels.
Studies using knockout mice orally infected by P. gingivalis, demonstrate that atherosclero­
sis, involving the accumulation of macrophages and inflammatory mediators (CD40, IL-1ß, 
IL-6, and TNF-α) in atherosclerotic lesions, is highly dependent on TLR2 [41, 83]. In correla­
tion, interaction between P. gingivalis and human blood cells, for example, platelets, neutro­
phils, monocytes, and T-cells, is mainly mediated by TLR2 and has dramatic inflammatory and 
immunomodulatory effects, including cellular aggregation, oxygen radical production, low-
density lipoprotein (LDL) oxidation, and release and degradation of cytokines. Furthermore, 
P. gingivalis changes the expression of more than thousand genes in vascular smooth muscle 
cells [84]. For example, P. gingivalis upregulates genes involved in proliferation, for example, 
the TGFβ1 pathway and production of matrix proteins, but downregulates pro-inflammatory 
genes, such as those involved in IL-1β, IL-6, and CXCL8 production. P. gingivalis also caused 
a dramatic increase in the expression of angiopoietin2 (ANGPT2), which is highly corre­
lated with inflammation and atherosclerosis, whereas ANGPT1, inhibitor of inflammation, 
was downregulated [85, 86]. These effects are mediated via gingipain R, possibly through 
PAR signaling. Furthermore, the level of another angiogenic factor, vascular endothelial 
Figure 2. A novel biochemical link between periodontitis and cardiovascular disease.
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growth factor (VEGF), increases in patients with periodontitis, and periodontal treatment 
reduces its concentration [87]. These data indicate that P. gingivalis causes a shift from contractile 
smooth muscle cells to proliferating and matrix-producing smooth muscle cells, which contrib­
utes to the growth of the fibrous atherosclerotic plaque, and promotes vascular inflammation 
and angiogenesis.
P. gingivalis has also been shown to modify LDL and promote phenotypic shift of monocytes 
to foam cells [75, 77, 88]. Our group has previously found fragmentation of the dominating 
apoprotein of LDL, apo B-100, by P. gingivalis and its Rgps [88]. Consequently, our findings 
together with others suggest that P. gingivalis during translocation in circulating blood modi­
fies LDL to an atherogenic form which may represent a link between periodontal disease and 
atherosclerosis (Figure 2).
6. Host cell responses in the circulation and vascular wall
Endothelial cells possess secretory and immunological properties and play therefore impor­
tant roles in the cardiovascular system. The association of periodontitis with cardiovascular 
complications includes the induction of endothelial dysfunction, oxidative stress, and sys­
temic inflammation [89]. Furthermore, patients with periodontitis have increased levels of 
pro-inflammatory mediators, including C-reactive protein (CRP), IL-6, and TNF that may 
induce endothelial dysfunction [90]. Endothelial dysfunction, which is the initial step in the 
development and progression of atherosclerosis, is mediated by endotoxins and gingipains 
of periodontal bacteria. These toxins lead to an impairment of normal endothelial function, 
including vessel permeability and immune cell adhesion and function [91, 92]. Furthermore, 
P. gingivalis and other periodontal pathogens induce the expression of endothelin-1, a potent 
vasoconstrictor released by endothelial cells [93, 94]. Endothelin-1 expression has shown a 
positive correlation to pro-inflammatory cytokines TNF, IL-6, and IL-1β [95], and a negative 
correlation to anti-inflammatory mediators, for example, angiopoietin-1 [96, 97].
Platelets are key players in hemostasis and acute thrombosis and are initial actors in the 
development of atherosclerotic lesions often triggered by endothelial dysfunction [98]. 
However, they are also involved in the immune system and express a broad repertoire of 
immune cell features such as TLRs, the immunoglobulin γ-receptor FcγRIIA, complement 
receptors, inflammatory mediators, as well as microbicidal activities, for example, throm­
bocidins [99, 100]. Furthermore, platelets bind to and encapsulate bacteria, release ROS and 
recruit and activate leukocytes and regulate inflammatory processes of the vessel wall [101]. 
These characteristics make it possible for platelets to recognize and respond to pathogens, 
such as P. gingivalis, and engage other immune cells for enhanced bacterial clearance and 
inflammatory response.
Several studies suggest that platelet-leukocyte interaction is an essential underlying inflam­
matory process in atherosclerosis, and patients with cardiovascular disease have an increased 
number of neutrophil-platelet aggregates in the blood circulation [102, 103]. In correlation, 
we have shown that P. gingivalis markedly induces the formation of large aggregates of 
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neutrophils and platelets, associated with ROS production and lipid peroxidation, in whole 
blood and that this effect is dependent on CD11b/CD18-fibrinogen-GpIIb/IIIa interaction, 
and Rac2 and Cdc42 activation [104, 105] (Figure 3). In addition, mice challenged with 
P. gingivalis were found to form platelet-neutrophil aggregates, whereas knockout TLR2−/− 
mice did not. Human platelets express TLRs (TLR 1, 2, 4, 6, and 9), which could be key 
molecules linking periodontal infection and CVD. For example, TLR2-mediated platelet 
activation involving the activation of GpIIb/IIIa and P-selectin contributes to the formation 
of platelet-leukocyte complexes and ROS production [99].
Platelets activation by TLR1/2 receptor ligands results in aggregation as well as secretion of 
inflammatory mediators such as RANTES, macrophage migration inhibitory factor (MIF), and 
plasminogen activator inhibitor-1 (PAI-1) [105]. Interestingly, these platelet-derived factors 
are degraded by gingipains from P. gingivalis [105]. Regulated on activation, normal T-cell 
expressed and secreted (RANTES) is induced by P. gingivalis and its lipopolysaccharides and 
is thus implicated in periodontitis, where elevated levels have been detected in the gingival 
crevicular fluid of patients with periodontitis [106]. It has been demonstrated that P. gingi-
valis, in addition to TLR2, also can trigger platelet activation via PAR receptors. Through the 
action of Rgp on PARs, P. gingivalis activates platelets by increasing intracellular-free calcium 
and induces aggregation [105]. In correlation, Lourbakos et al. and McNiol and Israels [107, 
108] have demonstrated that gingipains activate PAR1 and PAR4 on platelets leading to aggre­
gation and secretion. We have shown that P. gingivalis triggers platelet aggregation through 
Figure 3. Model showing platelets as a linker between periodontal infection and innate immune response at the vessel 
wall.
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 gingipain interaction with PARs and sensitizes platelets for activation by epinephrine, which 
may explain the association between periodontitis, stress and CVD [109].
7. Preventive and treatment strategies
Periodontal pathogens reside in biofilms of subgingival dental plaque and form complex 
polymicrobial communities. The failure of the immune system to resolve bacterial biofilms 
results in an accumulation of inflammatory mediators that accelerates the disease state toward 
a chronic inflammatory condition. Bacterial biofilms are difficult to treat, and conventional 
methods, including mechanical removal and scaling and root planning (SRP), are still being 
used. These methods are less efficient and new preventive/treatment strategies are needed. A 
new approach includes the administration of adjunctive antibiotics systemically in combina­
tion with SRP. Different antibiotics have been applied, and a combination of metronidazole 
and amoxicillin was found to be effective at reducing pocket depth and clinical attachment 
gain compared to SRP alone, reviewed in [110]. Although antibiotic therapy is effective in 
modern medicine, microorganisms that are resistant to single or multiple antibiotics have 
emerged. The development of new families of antibiotics has significantly declined, which is 
associated with high costs and concerns for possible effects on the commensal microbiota and 
host health [111]. It is evident that new alternative strategies to traditional antibiotic therapy 
are needed. New approaches to combat bacterial infections include antibodies, vaccines, 
bacteriophages, probiotics, and antimicrobial peptides (host- and bacteria-derived) [111–114]. 
These strategies of promising candidates to traditional antibiotics deserve more consideration.
8. Concluding remarks
In summary, it is possible that P. gingivalis has a role in pathogenic oral biofilms to undermine 
important factors of innate immunity, by altering the functions of receptors and their intracel­
lular signaling pathways and the levels of effector molecules, and thereby antagonizing an 
effective host response. These activities of key periodontal pathogens could contribute to an 
adaptation and maturation of dysbiotic biofilm communities and promote chronic inflam­
mation and tissue destruction of periodontitis. Increased understanding of the interbacte­
rial interactions that occur in the oral polymicrobial biofilm and its interplay with the host 
immune system is of uttermost importance for identifying novel targets for the prevention, 
diagnosis, and treatment of periodontitis and associated systemic disorders.
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